Fo

OTC products · Product label record

Foot Pain Relief Pads drug information

LIDOCAINE
Shanghai Chuangshi Medical Technology (Group) Co., Ltd. · TOPICAL

Product NDC: 73557-190

Join the community
CommunityExperiencesReviewsDrug database
Source label information, not individualized medical advice. This record applies to the product and labeler shown below. Compare the exact formulation, strength and country with your package and the current source label.
Generic nameLIDOCAINE
Labeler / manufacturerShanghai Chuangshi Medical Technology (Group) Co., Ltd.
RouteTOPICAL
Drug classAmide Local Anesthetic / Antiarrhythmic
Product NDC73557-190
Label effective date2026-08-25

Official product label reference

Foot Pain Relief Pads — Shanghai Chuangshi Medical Technology (Group) Co., Ltd.

This page contains 14 source sections for LIDOCAINE, topical route. Label set 5a18ff72-8a3e-5cdb-e063-6394a90a6162, version 1.

Retrieved 2026-10-02 · openFDA dataset updated 2026-10-02 · Check the current DailyMed label

Label records can cover multiple strengths or package sizes. A label listing does not by itself establish FDA approval or current market availability. Check the source and application history for this specific product.

Uses described in the label

Uses For temporary relief of pain

Purpose

Purpose Topical Anesthetic
Dosage and administration — label text
Directions Adult and children 12 years of age and over: • Clean and dry affected area • Remove film from patch and apply to the skin (see illustration) • Apply 1 patch at a time to affected area, not more than 3 to 4 times daily • Remove patch from the skin after at most 8‑hour application Children under 12 years of age: Consult a doctor
Warnings
Warnings For external use only
Active ingredient
Active ingredient Lidocaine 4% ...... Purpose: Topical Anesthetic
Do not use
Do not use •More than 1 patch at a time •On wounds or damaged skin •For more than one week without consulting a doctor •If you are allergic to any ingredients of this product
While using this medicine
When using this product •Use only as directed •Avoid contact with the eyes, mucous membranes or rashes •Do not bandage tightly
Ask a doctor before use
Ask a doctor if: •Localized skin reactions occur, such as rash, itching, redness, irritation, pain, swelling and blistering •Conditions worsen •Symptoms persist for more than 7 days •Symptoms clear up and occur again within a few days
When to stop use and seek help
Stop use if: •Localized skin reactions occur, such as rash, itching, redness, irritation, pain, swelling and blistering •Conditions worsen •Symptoms persist for more than 7 days •Symptoms clear up and occur again within a few days
Pregnancy or breast feeding
Pregnancy or breast feeding If pregnant or breastfeeding , ask a health professional before use
Child safety
Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center right away.
Storage and handling
Other information • Avoid storing product in direct sunlight • Protect product from excessive moisture
Inactive ingredient
Inactive ingredients Dihydroxyaluminum Aminoacetate, Edetate Disodium, Glycerin, Kaolin, Methylparaben, Polysorbate 80, PropyleneGlycol, Polyacrylic Acid, Polyvinylpyrrolidone K90, Propylparaben, Sodium Polyacrylate, Titanium Dioxide, Tartaric Acid, Water
Questions
Questions or Comments? webmaster@csigroup.com.cn

Official sources and product identifiers

Substances listed: LIDOCAINE

RxNorm identifiers: 1737778

Package NDC codes

73557-190-12

Further research and background

These are external searches for related information. Research, encyclopedia and news articles have not been imported into this product record.

Coverage and corrections

The text is extracted from a US structured product label. Tables are represented as text where supplied; formatting and illustrations may be lost. A missing section does not mean a risk is absent. This reference has not been independently reviewed by a clinician and is not a live safety-alert service.

Source retrieved 2026-10-02. Read the source policy.